46
Views
0
CrossRef citations to date
0
Altmetric
REVIEW

Targeting WEE1 Kinase in Gynecological Malignancies

, &
Pages 2449-2460 | Received 31 Jan 2024, Accepted 27 May 2024, Published online: 20 Jun 2024

Figures & data

Figure 1 WEE1 kinase in cell cycle regulation and DNA damage repair. ATR or ATM are employed during the G2/M checkpoint to detect DNA damage, depending on the type of genotoxic stress. The phosphorylation of ATR leads to activation of CHK1, which subsequently activates WEE1 and inactivates CDC25. Active WEE1 phosphorylates the CDK1-CyclinB complex at tyrosine 15, keeping the complex inactive and preventing cells from entering mitosis. The activation of ATM phosphorylates and activates CHK2, and subsequently promotes the cytoplasmic sequestration and inactivation of CDC25, which reduces the CDK1 activity and prevents cells entry into mitosis. After DNA damage repair, WEE1 activity is attenuated, the inhibitory phosphorylation of CDK1 is prevented, and the inhibitory effect of CHK1 and CHK2 on CDC25 is abolished. CDC25 dephosphorylates CDK1-CylinB, activates the complex, and drives cells into mitosis.

Abbreviations: ATR, Ataxia-telangiectasia-related; ATM, Ataxia-telangiectasia mutated; CHK1, Checkpoint kinase 1; CHK2, Checkpoint kinase 2; CDC25, Cell division cycle factor 25/Cell division cyclin 25, CDK1, Cyclin-dependent kinase 1.
Figure 1 WEE1 kinase in cell cycle regulation and DNA damage repair. ATR or ATM are employed during the G2/M checkpoint to detect DNA damage, depending on the type of genotoxic stress. The phosphorylation of ATR leads to activation of CHK1, which subsequently activates WEE1 and inactivates CDC25. Active WEE1 phosphorylates the CDK1-CyclinB complex at tyrosine 15, keeping the complex inactive and preventing cells from entering mitosis. The activation of ATM phosphorylates and activates CHK2, and subsequently promotes the cytoplasmic sequestration and inactivation of CDC25, which reduces the CDK1 activity and prevents cells entry into mitosis. After DNA damage repair, WEE1 activity is attenuated, the inhibitory phosphorylation of CDK1 is prevented, and the inhibitory effect of CHK1 and CHK2 on CDC25 is abolished. CDC25 dephosphorylates CDK1-CylinB, activates the complex, and drives cells into mitosis.

Table 1 WEE1 Inhibitor in Gynecologic Oncology Clinical Trials